Overview
Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.Phase:
Phase 2Details
Lead Sponsor:
Forbes Medi-Tech
Criteria
Inclusion Criteria:- Mild to moderate primary hypercholesterolemia
- Able to give informed consent and to comply with study procedures (including diet)
Exclusion Criteria:
- Homozygous familial hypercholesterolemia
- Age <18 or >75 years
- Pregnant women or women of child-bearing potential